BrilanestrantBrilanestrant (INN; developmental codes GDC-0810, ARN-810, RG-6046, and RO-7056118) is a nonsteroidal combined selective estrogen receptor modulator (SERM) and selective estrogen receptor degrader (SERD) that was discovered by Aragon Pharmaceuticals and was under development by Genentech for the treatment of locally… Read from the Drugbox of the Wikipedia article Brilanestrant, revision 1329034700.

Property

Value

Formula

C26H20ClFN2O2, 446.91 g/mol

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.